Table 3.
HLA-loss relapse | Classical relapse | |||
---|---|---|---|---|
Retrospective | Prospective | |||
Number of patients (n) | 4 | 2 | 16 | |
Patient ID# | 1–4 | 5,6 | 7–22 | |
Treatment at relapse | No treatment | 1 | - | 2 |
Chemotherapy | - | 2 | 9 | |
DLIs | - | - | 1 | |
DLIs plus chemotherapy | 3 | - | 4 | |
Severe GVHD after rescue treatment | 3 | - | 3 | |
OS | At 6 months | 50% | 100% | 31% |
At 1 year | 25% | 50% | 18% |
Detailed information on the rescue treatments used and on the clinical outcome is provided in Supplementary Table 2. Severe GVHD includes III-IV aGVHD and cGVHD. DLIs, donor lymphocyte infusions; GVHD, graft-vs.-host disease; OS, overall survival.